Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002244271 | SCV002512696 | uncertain significance | Acromicric dysplasia; Geleophysic dysplasia 2 | 2021-09-25 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PM2 moderate |
All of Us Research Program, |
RCV004804410 | SCV005424763 | uncertain significance | Marfan syndrome | 2024-03-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004820238 | SCV005441355 | uncertain significance | not provided | 2024-06-27 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; Does not affect a cysteine or calcium-binding residue within an EGF-like domain or a TGF-binding protein domain of the FBN1 gene; cysteine substitutions in the EGF-like domains represent the majority of pathogenic missense changes associated with FBN1-related disorders (PMID: 12938084); This variant is associated with the following publications: (PMID: 12938084) |